VeriMomSollte ich propylene glycol myristate in der Schwangerschaft meiden? | VeriMom
No authoritative reproductive hazard assessment (no harmonised H360/H361 in Annex VI was confirmed; no SCCS or CIR safety assessment indicating reproductive toxicity). As a fatty ester emollient, no pregnancy-specific toxicity data were found in available regulatory sources. Topical dermal absorption is expected to be low but measurable for such esters, so exposure is scored as low (e=1). Sources consulted: ECHA C&L (notifications), PubChem, CosIng, CIR, PubMed (no relevant reproductive studies found).
ECHA regulatory hazard statements
- •H361
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- Ist propylene glycol myristate in der Schwangerschaft sicher?
- No authoritative reproductive hazard assessment (no harmonised H360/H361 in Annex VI was confirmed; no SCCS or CIR safety assessment indicating reproductive toxicity). As a fatty ester emollient, no pregnancy-specific toxicity data were found in available regulatory sources. Topical dermal absorption is expected to be low but measurable for such esters, so exposure is scored as low (e=1). Sources consulted: ECHA C&L (notifications), PubChem, CosIng, CIR, PubMed (no relevant reproductive studies found).
- Ist propylene glycol myristate während des Stillens sicher?
- No evidence of reproductive or lactation-specific toxicity in authoritative reviews; no known mechanism for transfer into breast milk. Dermal absorption expected low but measurable leading to low maternal systemic exposure (e=1). Sources: same as for pregnancy (ECHA C&L self-notifications, PubChem, CosIng, CIR, PubMed).
- Ist propylene glycol myristate sicher für Babyhaut?
- No infant-specific toxicity or developmental data identified. Because infant skin has higher permeability and surface-area-to-weight, exposure score is increased by +1 relative to adults (adult e=1 → infant e=2). No evidence supports increased hazard or a reproductive mechanism in infants. Sources: CosIng, PubChem, ECHA C&L, PubMed (no infant-specific studies found).
- Wie bewertet VeriMom propylene glycol myristate?
- VeriMom bewertet propylene glycol myristate mit 33/100 (hohes Risiko) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu propylene glycol myristate?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu propylene glycol myristate basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.